RBC Boosts Price Target on Pyxis Oncology to $10 From $7, Keeps Outperform, Speculative Risk
RBC Boosts Price Target on Pyxis Oncology to $10 From $7, Keeps Outperform, Speculative Risk
瑞士信貸將Pyxis Oncology的目標價格從7美元上調至10美元，維持表現優於大盤，具有投機風險。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間